Gilead Sciences Management
Management criteria checks 3/4
Gilead Sciences' CEO is Dan O'Day, appointed in Mar 2019, has a tenure of 5.58 years. total yearly compensation is $22.61M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth CLP40.96B. The average tenure of the management team and the board of directors is 4.7 years and 6.4 years respectively.
Key information
Dan O'Day
Chief executive officer
US$22.6m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 5.6yrs |
| CEO ownership | 0.04% |
| Management average tenure | 4.7yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$485m |
| Dec 31 2023 | US$23m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$22m | US$2m | US$5b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$4b |
| Mar 31 2022 | n/a | n/a | US$5b |
| Dec 31 2021 | US$19m | US$2m | US$6b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$5b |
| Mar 31 2021 | n/a | n/a | US$301m |
| Dec 31 2020 | US$19m | US$2m | US$123m |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | -US$257m |
| Mar 31 2020 | n/a | n/a | US$5b |
| Dec 31 2019 | US$29m | US$1m | US$5b |
Compensation vs Market: Dan's total compensation ($USD22.61M) is above average for companies of similar size in the CL market ($USD5.82M).
Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.
CEO
Dan O'Day (60 yo)
5.6yrs
Tenure
US$22,607,690
Compensation
Mr. Daniel P. O'Day, also known as Dan, served as Non-Executive Non-Independent Director for Galapagos NV since October 22, 2019 until March 26, 2024. He served as Member of Supervisory Board at Galapagos...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.6yrs | US$22.61m | 0.040% CLP 41.0b | |
| Chief Financial Officer | 4.9yrs | US$8.11m | 0.011% CLP 11.5b | |
| Executive VP of Corporate Affairs | 2.2yrs | US$5.27m | 0.0017% CLP 1.7b | |
| Chief Commercial Officer | 5.3yrs | US$8.59m | 0.0063% CLP 6.5b | |
| Chief Medical Officer | 4.9yrs | US$8.39m | 0.0080% CLP 8.3b | |
| Senior VP | 1.6yrs | no data | 0.0029% CLP 3.0b | |
| Vice President of Investor Relations | 3.8yrs | no data | no data | |
| Executive Vice President of Human Resources | 5.2yrs | no data | no data | |
| Senior Vice President of Research | 4.7yrs | no data | no data | |
| Senior Vice President of Commercial Operations of Australia | no data | no data | no data | |
| Executive Vice President of Research | 3.5yrs | no data | no data | |
| Senior Vice President & Therapeutic Area Head of Gilead Oncology | 3.3yrs | no data | no data |
4.7yrs
Average Tenure
58yo
Average Age
Experienced Management: GILDCL's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.6yrs | US$22.61m | 0.040% CLP 41.0b | |
| Lead Independent Director | 4yrs | US$444.92k | 0.00082% CLP 843.0m | |
| Member of Scientific Advisory Board | no data | US$16.00k | no data | |
| Independent Director | 6.8yrs | US$429.92k | 0.0020% CLP 2.0b | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.4yrs | US$414.92k | 0.0010% CLP 1.1b | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.2yrs | US$434.92k | 0.00011% CLP 113.1m | |
| Chairperson of Scientific Advisory Board | no data | no data | no data |
6.4yrs
Average Tenure
71yo
Average Age
Experienced Board: GILDCL's board of directors are considered experienced (6.4 years average tenure).